TC BioPharm (Holdings) plc - ADR

The momentum for this stock is not very good. TC BioPharm (Holdings) plc - ADR is not very popular among insiders. Tradey thinks it is not wise to invest in TC BioPharm (Holdings) plc - ADR.
Log in to see more information.

News

TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial
TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial

PR Newswire TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial PR Newswire EDINBURGH...\n more…

TC Biopharm (Holdings) PLC - ADR trading resumes
TC Biopharm (Holdings) PLC - ADR trading resumes

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

TC Biopharm (Holdings) PLC - ADR trading halted, volatility trading pause
TC Biopharm (Holdings) PLC - ADR trading halted, volatility trading pause

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

TC Biopharm intends to launch preclinical study for treatment of Mpox
TC Biopharm intends to launch preclinical study for treatment of Mpox

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox
TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox

PR Newswire TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox PR Newswire EDINBURGH, Scotland, Sept. 9...\n more…

TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox
TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox

PR Newswire TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox PR Newswire EDINBURGH, Scotland, Sept. 6...\n more…